UCB SA at JPMorgan Healthcare Conference (Virtual) Transcript
Good morning, and good afternoon. Welcome to the 39th JPMorgan Healthcare Conference. I'm Richard Vosser, European pharma analyst at JPMorgan, and it's my great pleasure to introduce Jean-Christophe Tellier, CEO of UCB, to this session.
Before I hand over to Jean-Christophe, I'd like to remind everyone that they can ask a question at any time by using the Q&A function on the website. And then at the Q&A appropriate time, I will ask that question for you. With that, I'd like to say thanks very much, Jean-Christophe, for joining us. Welcome. Jean-Christophe, over to you.
Thank you, Richard. Good morning, good afternoon, everyone, and thank you for joining this presentation. It is my pleasure to share with you some insights about UCB and where we are. So if we move to Slide 2, you can see the classical disclaimer and safe harbor.
But I would like to go to Slide 3 now because I think
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
